Regeneration Biomedical doses first patient in phase I trial of stem cell therapy to deliver directly to brain of ...
Regeneration Biomedical, Inc, a clinical-stage company developing autologous stem cell treatments for neurodegenerative diseases, announced that the first patient has been dosed in an FDA-cleared, first-in-human phase 1 clinical trial of autologous, Wnt- …